Harald Rau,Thomas Knappe,Burkhardt Laufer,Romy Reimann,Samuel Weisbrod,Kennett Sprogøe,Nicola Bisek,Sebastian Stark,Tobias Voigt
申请号：
US14435350
公开号：
US10519226B2
申请日:
2013.10.08
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising one or more pharmaceutically acceptable excipient(s) and a VEGF neutralizing prodrug, which comprises a VEGF neutralizing biologically active moiety, for use in a method for the treatment of one or more ocular conditions.
